TAO Synergies (TAOX) Cash & Equivalents (2019 - 2026)

TAO Synergies has disclosed Cash & Equivalents across 8 years of filings, most recently posting $3.6 million for Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 75.42% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (down 75.42% YoY), and the FY2025 full-year result was $5.5 million, down 68.86% from the prior year.
• Cash & Equivalents was $3.6 million for Q1 2026 at TAO Synergies, down from $5.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $37.5 million in Q4 2022 and troughed at $3.6 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $26.3 million (2022), against an average of $23.7 million.
• The sharpest annual moves came in 2022 and 2026: Cash & Equivalents soared 111.36% in 2022, then plunged 75.42% in 2026.
• Year by year, Cash & Equivalents stood at $37.5 million in 2022, then declined by 23.47% to $28.7 million in 2023, then plunged by 38.48% to $17.7 million in 2024, then tumbled by 68.86% to $5.5 million in 2025, then slumped by 33.68% to $3.6 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $3.6 million in Q1 2026, $5.5 million in Q4 2025, and $14.4 million in Q2 2025.